Enovis Corp Proceeds from Long-term Lines of Credit
Enovis Corp (ENOV) reported Proceeds from Long-term Lines of Credit of $104.39 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-06
- Enovis Corp proceeds from long-term lines of credit for the quarter ending 2026-07-03 was $32.39M, a 41.11% decline year-over-year.
- Enovis Corp proceeds from long-term lines of credit for the quarter ending 2026-04-03 was $72.00M, a 0.00% change year-over-year.
- Enovis Corp proceeds from long-term lines of credit for the quarter ending 2025-12-31 was $32.00M, a 38.46% decline year-over-year.
- Enovis Corp proceeds from long-term lines of credit for the quarter ending 2025-10-03 was $50.00M.
- Enovis Corp proceeds from long-term lines of credit for fiscal 2025 was $209.00M, a 78.93% decline from fiscal 2024.
- Enovis Corp proceeds from long-term lines of credit for fiscal 2024 was $992.00M, a 118.02% increase from fiscal 2023.
- Enovis Corp proceeds from long-term lines of credit for fiscal 2023 was $455.00M, a 600.00% increase from fiscal 2022.
- Enovis Corp proceeds from long-term lines of credit for fiscal 2022 was $65.00M, a 93.44% decline from fiscal 2021.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-07-03 | $32.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $104.39M 10-Q · filed 2026-08-06 | $136.39M derived: sum of 3 quarters · filed 2026-08-06 | $186.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $72.00M 10-Q · filed 2026-05-07 | $104.00M derived: sum of 2 quarters · filed 2026-05-07 | $154.00M derived: sum of 3 quarters · filed 2026-05-07 | $209.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $82.00M derived: sum of 2 quarters · filed 2026-02-26 | $137.00M derived: sum of 3 quarters · filed 2026-08-06 | $209.00M 10-K · filed 2026-02-26 |
| 2025-10-03 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $105.00M derived: sum of 2 quarters · filed 2026-08-06 | $177.00M 10-Q · filed 2025-11-06 | $229.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-07-04 | $55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $127.00M 10-Q · filed 2026-08-06 | $179.00M derived: sum of 3 quarters · filed 2026-08-06 | $179.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-04-04 | $72.00M 10-Q · filed 2026-05-07 | $124.00M derived: sum of 2 quarters · filed 2026-05-07 | $124.00M derived: sum of 3 quarters · filed 2026-05-07 | $584.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.00M derived: sum of 2 quarters · filed 2026-02-26 | $512.00M derived: sum of 3 quarters · filed 2026-02-26 | $992.00M 10-K · filed 2026-02-26 |
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $460.00M derived: sum of 2 quarters · filed 2025-11-06 | $940.00M 10-Q · filed 2025-11-06 | $995.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-28 | $460.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $940.00M 10-Q · filed 2025-08-07 | $995.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.02B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-29 | $480.00M 10-Q · filed 2025-05-08 | $535.00M derived: sum of 2 quarters · filed 2026-02-26 | $565.00M derived: sum of 3 quarters · filed 2026-02-26 | $685.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $85.00M derived: sum of 2 quarters · filed 2026-02-26 | $205.00M derived: sum of 3 quarters · filed 2026-02-26 | $455.00M 10-K · filed 2026-02-26 |
| 2023-09-29 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $150.00M derived: sum of 2 quarters · filed 2024-11-06 | $400.00M 10-Q · filed 2024-11-06 | $465.00M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $120.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $370.00M 10-Q · filed 2024-08-07 | $435.00M derived: sum of 3 quarters · filed 2025-02-26 | |
| 2023-03-31 | $250.00M 10-Q · filed 2024-05-02 | $315.00M derived: sum of 2 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $65.00M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $991.49M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |